Our people

“Partnering is about bringing together the most talented people with different backgrounds to solve complex tasks, which I find very rewarding. In my role, I am fortunate to experience many different aspects of AstraZeneca’s business and how it all fits together. The energy within these walls is remarkable.”

Fredrik Röök, Transaction Director, Business Development Operations

View Fredrik's profile

Our people

"What drives me the most is solving difficult problems, in collaboration with others, for the benefit of the patient and the business."

Mark Fielding, Associate Principal Scientist, Global Medicines Development

View Mark's profile

Our people

"There is an expanding universe of biological data available which can revolutionise our understanding of disease and therapy if we find innovative ways to share and explore it."

Jonathan Dry, Principal Scientist, Bioinformatics, Oncology, IMED Biotech Unit

View Jonathan's profile

Our people

"I believe personalised healthcare is the future of medicine; it allows us to use the latest diagnostic science to target medicines to patients most likely to benefit."

Ruth March, Senior Vice-President of Precision Medicine and Genomics, IMED Biotech Unit

View Ruth's profile

Jason Snape

Global Safety, Health and Environment Director and Senior Principal Environmental Scientist

Elisabeth Björk

Senior Vice President and Head of Late Cardiovascular, Renal and Metabolic (CVRM), R&D BioPharmaceuticals

John Houghton

Global Medicine Leader

Lutz Jermutus PhD

Senior Director, R&D, and Product Development Team Leader, Cardiovascular, Metabolic and Renal Disease, Innovative Medicines and Early Development

Rodrigo Gribble Escobar

Vice President, Cardiovascular

Anna Sundgren, PhD, MBA

Global Development Leader
 

Rahul Agrawal, MD, MBA

Vice-President, Global Medicines Leader, Cardiovascular

José Baselga, M.D., Ph.D.

Executive Vice-President, Research & Development Oncology

Garry Pairaudeau

Head of Hit Discovery, IMED Biotech Unit
 

Ola Engkvist

Associate Director, Discovery Sciences Computational Chemistry, IMED Biotech Unit

Clive Green

Executive Director and Head of Global Sample Management, IMED Biotech Unit

Dr Danilo Verge, BSc (Hons), MBA, MD

Vice President, Cardiovascular, Renal and Metabolism, Global Medical Affairs
 

Tom Keith-Roach

Therapy Area Vice President, Respiratory
 

Colin Reisner

Head, Respiratory Global Medicines, AstraZeneca and CEO of Pearl Therapeutics

Rene van der Merwe

Vice President, Clinical Respiratory
 

Qing-Dong Wang

Senior Principal Scientist, IMED Biotech Unit

Maria Belvisi

Vice President and Head, RIA Innovative Medicines

Ralph Knöll

Chief Scientist, IMED CVRM

David Keeling

Project Director, Respiratory, Inflammation & Autoimmunity, IMED Biotech Unit

Susan Galbraith

Senior Vice President and Head of Oncology, IMED Biotech Unit
 

Roland Kolbeck

PhD, VP, R&D Respiratory, Inflammation and Autoimmunity (RIA)

Stephen Delaney

Associate Director, Respiratory, Inflammation & Autoimmunity, IMED Biotech Unit

Benoit Destenaves

Director, Molecular Diagnostics Labs and Pharmacogenomics, IMED Biotech Unit

Katerina Pardali

Associate Principal Scientist, Respiratory, Inflammation & Autoimmunity, IMED Biotech Unit

Regina Fritsche-Danielson

Vice President and Head of Cardiovascular, Renal and Metabolism, IMED Biotech Unit

View Regina's profile

Jonathan Dry

Principal Scientist, Bioinformatics, Oncology, Innovative Medicines & Early Development

View Jonathan's profile

Ruth March

Vice-President and Head of Personalised Healthcare and Biomarkers, IMED Biotech Unit

View Ruth's profile

Li-Ming Gan

Medical Science Director, Early Clinical Development (Cardiovascular and Metabolism), IMED Biotech Unit

Shaun Grady

Vice-President Business Development Operations

Maria Groves

Associate Director, Head of the CRUK MedImmune Alliance Laboratory (CMAL)

Mark Fielding

Associate Principal Scientist, Global Medicines Development

William Dall’Acqua

Senior Director, R&D, Antibody Discovery and Protein Engineering, MedImmune

Mark O’Connor

Chief Scientist, Oncology, IMED Biotech Unit

Slavé Petrovski

Vice-president and Head of Genome Analytics for AstraZeneca Centre for Genomics Research (CGR), Cambridge, UK

Paul Harper

Associate Principal Scientist, Discovery Sciences, IMED Biotech Unit

Jane Osbourn

Vice-President Research and Development, MedImmune

View Jane's profile

Menelas Pangalos

Executive Vice-President, Research & Development BioPharmaceuticals

View Menelas's profile

Fredrik Röök

Transaction Director, Business Development Operations

View Fredrik's profile

Elisa Lázaro Ibáñez

Postdoctoral Researcher -  IMED Biotech Unit, AstraZeneca Gothenburg

Per Lindblom

Global Products Manager, GMD - Cardiovascular, Renal and Metabolic Diseases

Project Lead, IMED Biotech unit - Cardiovascular, Renal and Metabolic Diseases

Ella Ekholm

Senior Medical Lead, Cardiovascular, Renal and Metabolism, Global Medicines Development (GMD) - Gothenburg

Ramon Nogueras

Regional Director EMEA, Global Real Estate

Kumar Srinivasan

Vice-President, Scientific Partnering and Alliances, IMED Biotech Unit and Site Head, R&D Boston

Helen Angell

Principal Scientist, Oncology, Translational Sciences, IMED Biotech Unit

Emma Dean

Director, Early Phase Oncology, Early Clinical Development, IMED Biotech Unit

Amy Taylor

Associate Director, Strategic Planning and Operations, Early Clinical Development, IMED Biotech Unit and Chair of the Network of Women UK

Christopher J. Rhodes

VP, Cardiovascular & Metabolic Disease Research, MedImmune

Nicolas Jose Guzman

Director, Nephrology Clinical Research

David Wilson

Senior Director and Global Head of Oncology Chemistry, IMED Biotech Unit

Herren Wu

Chief Technology Officer and Global Head of Antibody Discovery and Protein Engineering (ADPE), MedImmune

Our focus areas

Cardiovascular, Renal and Metabolism

Oncology

Respiratory

Inflammation and Autoimmunity

Neuroscience

Infection and Vaccines